Nanobiotix reels in $18.5m tranche from European Investment Bank

Nanobiotix (PAR:NANO.PA) received €16 million ($18.5 million) in the first tranche of a previously-announced non-dilutive loan from the European Investment Bank.
The five-year funding deal is designed to support the company’s development of nanoparticle-based cancer therapies.
Get the full story at our sister site, Drug Delivery Business News.
The post Nanobiotix reels in $18.5m tranche from European Investment Bank appeared first on MassDevice.

Source: Mass Device - October 17, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Oncology Pharmaceuticals Wall Street Beat nanobiotix Source Type: news